Therese M-L Andersson1, Anna L V Johansson, Chung-Cheng Hsieh, Sven Cnattingius, Mats Lambe. 1. From the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; the Division of Biostatistics and Epidemiology, UMass Memorial Cancer Center, Worcester, Massachusetts; the Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; and the Regional Oncologic Center, Uppsala, Sweden.
Abstract
OBJECTIVE: To estimate the incidence of pregnancy-associated breast cancer during different calendar periods and when pregnancy-associated breast cancer was diagnosed in relation to delivery. METHODS: This was a population-based cohort study using data from Swedish registers between 1963 and 2002, encompassing women aged 15-44 years at the date of breast cancer diagnosis. Outcome measures included incidence of pregnancy-associated breast cancer per 100,000 deliveries, the proportion of pregnancy-associated breast cancer among all breast cancers, and observed-to-expected rates. RESULTS: Between 1963 and 2002, 1,161 cases of pregnancy-associated breast cancer among a total of 16,620 breast cancers were identified in women aged 15 to 44 years. The incidence of pregnancy-associated breast cancer increased from 16.0 to 37.4 per 100,000 deliveries comparing the first and last calendar periods under study. During pregnancy, the overall incidence was 2.4 per 100,000 deliveries; the incidence during the first and second year after delivery was 10.6 and 15.0 per 100,000 deliveries, respectively. Fewer pregnancy-associated breast cancers than expected were diagnosed during pregnancy and the first 6 months after delivery. Thereafter, there was no difference between observed compared with expected number of breast cancers. CONCLUSION: The incidence of pregnancy-associated breast cancer increased during the study period, partly caused by a trend of postponement of childbearing to an older age. The present findings suggest that breast cancer is underdiagnosed during pregnancy and lactation. LEVEL OF EVIDENCE: III.
OBJECTIVE: To estimate the incidence of pregnancy-associated breast cancer during different calendar periods and when pregnancy-associated breast cancer was diagnosed in relation to delivery. METHODS: This was a population-based cohort study using data from Swedish registers between 1963 and 2002, encompassing women aged 15-44 years at the date of breast cancer diagnosis. Outcome measures included incidence of pregnancy-associated breast cancer per 100,000 deliveries, the proportion of pregnancy-associated breast cancer among all breast cancers, and observed-to-expected rates. RESULTS: Between 1963 and 2002, 1,161 cases of pregnancy-associated breast cancer among a total of 16,620 breast cancers were identified in women aged 15 to 44 years. The incidence of pregnancy-associated breast cancer increased from 16.0 to 37.4 per 100,000 deliveries comparing the first and last calendar periods under study. During pregnancy, the overall incidence was 2.4 per 100,000 deliveries; the incidence during the first and second year after delivery was 10.6 and 15.0 per 100,000 deliveries, respectively. Fewer pregnancy-associated breast cancers than expected were diagnosed during pregnancy and the first 6 months after delivery. Thereafter, there was no difference between observed compared with expected number of breast cancers. CONCLUSION: The incidence of pregnancy-associated breast cancer increased during the study period, partly caused by a trend of postponement of childbearing to an older age. The present findings suggest that breast cancer is underdiagnosed during pregnancy and lactation. LEVEL OF EVIDENCE: III.
Authors: Ciara C O'Sullivan; Sheeba Irshad; Zheyu Wang; Zhuojun Tang; Christopher Umbricht; Gary L Rosner; Mindy S Christianson; Vered Stearns; Karen Lisa Smith Journal: Breast Cancer Res Treat Date: 2020-03-11 Impact factor: 4.872
Authors: Derman Basaran; Mert Turgal; Kemal Beksac; Ozgur Ozyuncu; Omer Aran; M Sinan Beksac Journal: Breast Care (Basel) Date: 2014-10 Impact factor: 2.860
Authors: Wenlian Zhu; Susan Harvey; Katarzyna J Macura; David M Euhus; Dmitri Artemov Journal: Clin Breast Cancer Date: 2016-07-28 Impact factor: 3.225
Authors: Lisa Prior; Richard O'Dwyer; Abdul Rehman Farooq; Megan Greally; Cian Ward; Connor O'Leary; Razia Aslam; Waseem Darwish; Nada Ahmed; Elly Che Othman; Geoffrey Watson; Deirdre Kelly; Jack Gleeson; Lisa Kiely; Anees Hassan; Elaine M Walsh; David O'Reilly; Alfred Jones; Hannah Featherstone; Marvin Lim; Hazel Murray; Bryan T Hennessy; Lillian M Smyth; Gregory Leonard; Liam Grogan; Oscar Breathnach; Paula Calvert; Anne M Horgan; Linda Coate; Emmet J Jordan; Deirdre O'Mahony; Rajnish Gupta; Maccon M Keane; Jennifer Westrup; Karen Duffy; Miriam O'Connor; Patrick G Morris; M John Kennedy; Seamus O'Reilly; John McCaffrey; Catherine M Kelly; Desmond Carney; Giuseppe Gullo; John Crown; Michaela J Higgins; Paul M Walsh; Janice M Walshe Journal: Breast Cancer Res Treat Date: 2021-06-14 Impact factor: 4.872
Authors: Katarzyna J Jerzak; Nechama Lipton; Sharon Nofech-Mozes; Dina Boles; Elzbieta Slodkowska; Gregory R Pond; Ellen Warner Journal: Breast Cancer Res Treat Date: 2021-07-27 Impact factor: 4.872
Authors: Jennifer K Litton; Carla L Warneke; Karin M Hahn; Shana L Palla; Henry M Kuerer; George H Perkins; Elizabeth A Mittendorf; Chad Barnett; Ana M Gonzalez-Angulo; Gabriel N Hortobágyi; Richard L Theriault Journal: Oncologist Date: 2013-04-10